Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The association of IL-18 gene promoter polymorphisms and the levels of serum IL-18 on the risk of multiple sclerosis.
Evaluation of Methods for the Inclusion of Real World Evidence in Network Meta-Analysis - A Case Study in Multiple Sclerosis.
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study.
Sodium intake is associated with increased disease activity in multiple sclerosis.
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
Astrocytes in multiple sclerosis.
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
[The biological role of sulfatides].
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.
Co-occurrence of multiple sclerosis and Parkinson disease.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
Quantitative Susceptibility Mapping Indicates a Disturbed Brain Iron Homeostasis in Neuromyelitis Optica - A Pilot Study.
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice.
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Glial progenitor cell-based treatment of the childhood leukodystrophies.
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
Chronic pain disrupts the reward circuitry in multiple sclerosis.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial.
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.

Pages